Expression of complement C5a receptor and the viability of 4T1 tumor cells following agonist-antagonist treatment.

Background: Complement system is theoretically believed to halt the progression of tumor by the activity of C5a/CD88. Protein C5a is a potent pro.inflammatory mediator that activates the complement system by binding to its receptor.